水銀中毒治療の世界市場2020-2030:産業分析、規模、シェア、成長、動向、予測

• 英文タイトル:Mercury Poisoning Treatment Market (Drug: Chelating Agents [Dimercaprol or British anti-Lewisite {BAL}, Dimercaptosuccinic Acid {DMSA}, DMPS, Penicillamine, and Others], Combination Therapy with Chelating Agents, and Plasma Exchange Hemodialysis Plasmapheresis; Type: Acute Mercury Poisoning and Chronic Mercury Poisoning; Treatment Type: Supportive Treatment and Antidotal Treatment; Form: Inorganic Mercury, Elemental Mercury, and Organic Mercury; Route of Administration: Injectable and Oral; and Distribution Channel: Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Mercury Poisoning Treatment Market (Drug: Chelating Agents [Dimercaprol or British anti-Lewisite {BAL}, Dimercaptosuccinic Acid {DMSA}, DMPS, Penicillamine, and Others], Combination Therapy with Chelating Agents, and Plasma Exchange Hemodialysis Plasmapheresis; Type: Acute Mercury Poisoning and Chronic Mercury Poisoning; Treatment Type: Supportive Treatment and Antidotal Treatment; Form: Inorganic Mercury, Elemental Mercury, and Organic Mercury; Route of Administration: Injectable and Oral; and Distribution Channel: Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030「水銀中毒治療の世界市場2020-2030:産業分析、規模、シェア、成長、動向、予測」(市場規模、市場予測)調査レポートです。• レポートコード:TMR2008055
• 出版社/出版日:Transparency Market Research / 2020年5月
• レポート形態:英文、PDF、242ページ
• 納品方法:Eメール
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥614,270 (USD5,795)▷ お問い合わせ
  Multi User¥932,270 (USD8,795)▷ お問い合わせ
  Corporate License¥1,250,270 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは水銀中毒治療の世界市場について調査・分析し、序文、仮定・調査手法、エグゼクティブサマリー、市場概要、市場見通し、薬物別(キレート剤、キレート剤併用療法、血漿交換血液透析血漿交換)分析、種類別(急性水銀中毒、慢性水銀中毒)分析、治療別(支持療法、解毒剤治療)分析、フォーム別(無機水銀、エレメンタル水銀、有機水銀)分析、投与経路別(注射剤、経口)分析、流通チャンネル別(病院薬局、オンライン薬局、小売薬局)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などを含め、以下の構成でご提供いたします。
・序文
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・市場見通し
・水銀中毒治療の世界市場:薬物別(キレート剤、キレート剤併用療法、血漿交換血液透析血漿交換)
・水銀中毒治療の世界市場:種類別(急性水銀中毒、慢性水銀中毒)
・水銀中毒治療の世界市場:治療別(支持療法、解毒剤治療)
・水銀中毒治療の世界市場:フォーム別(無機水銀、エレメンタル水銀、有機水銀)
・水銀中毒治療の世界市場:投与経路別(注射剤、経口)
・水銀中毒治療の世界市場:流通チャンネル別(病院薬局、オンライン薬局、小売薬局)
・水銀中毒治療の世界市場:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

Mercury Poisoning Treatment Market – Scope of the Report

TMR’s report on the global mercury poisoning treatment market studies past as well as current growth trends and opportunities to gain valuable insights for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global mercury poisoning treatment market for period from 2018 to 2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global mercury poisoning treatment market for the same period.

The report has been prepared after extensive research. Primary research involved a bulk of research efforts, wherein analysts conducted interviews with market leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global mercury poisoning treatment market.

Secondary research also includes Internet sources and statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of top-down and bottom-up approaches to study various phenomena in the global mercury poisoning treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth pattern of various market segments included in the scope of the study. Furthermore, the report sheds light on the changing competition dynamics in the global mercury poisoning treatment market. These indices serve as valuable tools for existing market players as well as new players interested in entering the global mercury poisoning treatment market. The next section of the report highlights the USPs, which includes, mercury poisoning overview, research & development strategies & pipeline analysis, treatment cost globally by key regions, drug prices globally by key regions, and COVID-19 pandemic impact on industry (value chain and short/mid/long-term impact).

The report delves into the competition landscape of the global mercury poisoning treatment market. Key players operating in the global mercury poisoning treatment market have been identified and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players operating in the global mercury poisoning treatment market profiled in this report.

Key Questions Answered in Report on Mercury Poisoning Treatment Market

What are the major drivers, restraints, and opportunities in the global mercury poisoning treatment market?
What would be the revenue share projection of key segments of the global mercury poisoning treatment market during the forecast period?
Which segment is likely to lead the global mercury poisoning treatment market, in terms of revenue, between 2020 and 2030?
How mergers & acquisitions among players are widening the scope for the global mercury poisoning treatment market?
What is the market position of different companies operating in the global mercury poisoning treatment market?
Mercury Poisoning Treatment Market – Research Objectives and Research Approach

The comprehensive report on the global mercury poisoning treatment market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of objectives of this study and healthcare compliances laid down by accredited agencies in the purview of research in the global mercury poisoning treatment market. It is followed by market introduction, market dynamics, and an overview of the global mercury poisoning treatment market, which includes TMR’s analysis of market drivers, restraints, and trends pertaining to the global mercury poisoning treatment market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global mercury poisoning treatment market. The next section of the global mercury poisoning treatment report highlights the USPs, which include mercury poisoning overview, research & development strategies & pipeline analysis, treatment cost globally by key regions, drug prices globally by key regions, and COVID-19 pandemic impact on industry (value chain and short/mid/long-term impact).

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report segments the global mercury poisoning treatment market in terms of drug, type, treatment type, form, route of administration, distribution channel, and region. Key segments under each criterion have been studied at length and the market share for each segment by the end of 2030 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the global mercury poisoning treatment market.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Mercury Poisoning Treatment Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Mercury Poisoning Treatment Market Analysis and Forecast, 2018–2030

5. Market Outlook

5.1. Mercury Poisoning Overview

5.2. Research and Development Strategies & Pipeline Analysis

5.3. Treatment Cost – Global – By Key Regions

5.4. Drug Prices – Global – By Key Regions

5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short /Mid / Long-term Impact) Pricing Analysis

6. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug

6.1. Introduction & Definition

6.2. Global Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030

6.2.1. Chelating Agents

6.2.1.1. Dimercaprol or British anti-Lewisite (BAL)

6.2.1.2. Dimercaptosuccinic Acid (DMSA)

6.2.1.3. DMPS

6.2.1.4. Penicillamine

6.2.1.5. Others

6.2.2. Combination Therapy with Chelating Agents

6.2.3. Plasma Exchange Hemodialysis Plasmapheresis

6.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Drug

7. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type

7.1. Introduction & Definition

7.2. Global Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030

7.2.1. Acute Mercury Poisoning

7.2.2. Chronic Mercury Poisoning

7.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Type

8. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type

8.1. Introduction

8.2. Global Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030

8.2.1. Supportive Treatment

8.2.2. Antidotal Treatment

8.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Treatment Type

9. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form

9.1. Introduction

9.2. Global Mercury Poisoning Treatment Market Value Forecast, by Form, 2018–2030

9.2.1. Inorganic Mercury

9.2.2. Elemental Mercury

9.2.3. Organic Mercury

9.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Form

10. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration

10.1. Introduction

10.2. Global Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030

10.2.1. Injectable

10.2.2. Oral

10.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Route of Administration

11. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel

11.1. Introduction

11.2. Global Mercury Poisoning Treatment Market Value Forecast, by End-user, 2018–2030

11.2.1. Hospital Pharmacies

11.2.2. Online Pharmacies

11.2.3. Retail Pharmacies

11.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by End-user

12. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Region

12.1. Introduction

12.2. Global Mercury Poisoning Treatment Market Value Forecast, by Region, 2018–2030

12.2.1. North America

12.2.2. Europe

12.2.3. Asia Pacific

12.2.4. Latin America

12.2.5. Middle East & Africa

12.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Region

13. North America Mercury Poisoning Treatment Market Analysis and Forecast

13.1. Introduction

13.2. North America Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030

13.2.1. Chelating Agents

13.2.1.1. Dimercaprol or British anti-Lewisite (BAL)

13.2.1.2. Dimercaptosuccinic Acid (DMSA)

13.2.1.3. DMPS

13.2.1.4. Penicillamine

13.2.1.5. Others

13.2.2. Combination Therapy with Chelating Agents

13.2.3. Plasma Exchange Hemodialysis Plasmapheresis

13.3. North America Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030

13.3.1. Acute Mercury Poisoning

13.3.2. Chronic Mercury Poisoning

13.4. North America Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030

13.4.1. Supportive Treatment

13.4.2. Antidotal Treatment

13.5. North America Mercury Poisoning Treatment Market Value Forecast, by Form 2018–2030

13.5.1. Inorganic Mercury

13.5.2. Elemental Mercury

13.5.3. Organic Mercury

13.6. North America Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030

13.6.1. Injectable

13.6.2. Oral

13.7. North America Mercury Poisoning Treatment Market Value Forecast, by Distribution Channel, 2018–2030

13.7.1. Hospital Pharmacies

13.7.2. Online Pharmacies

13.7.3. Retail Pharmacies

13.8. North America Mercury Poisoning Treatment Market Value Forecast, by Country, 2018–2030

13.8.1. U.S.

13.8.2. Canada

13.9. North America Mercury Poisoning Treatment Market Attractiveness Analysis

13.9.1. By Drug

13.9.2. By Type

13.9.3. By Treatment Type

13.9.4. By Form

13.9.5. By Route of Administration

13.9.6. By Distribution Channel

13.9.7. By Country

14. Europe Mercury Poisoning Treatment Market Analysis and Forecast

14.1. Introduction

14.2. Europe Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030

14.2.1. Chelating Agents

14.2.1.1. Dimercaprol or British anti-Lewisite (BAL)

14.2.1.2. Dimercaptosuccinic Acid (DMSA)

14.2.1.3. DMPS

14.2.1.4. Penicillamine

14.2.1.5. Others

14.2.2. Combination Therapy with Chelating Agents

14.2.3. Plasma Exchange Hemodialysis Plasmapheresis

14.3. Europe Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030

14.3.1. Acute Mercury Poisoning

14.3.2. Chronic Mercury Poisoning

14.4. Europe Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030

14.4.1. Supportive Treatment

14.4.2. Antidotal Treatment

14.5. Europe Mercury Poisoning Treatment Market Value Forecast, by Form 2018–2030

14.5.1. Inorganic Mercury

14.5.2. Elemental Mercury

14.5.3. Organic Mercury

14.6. Europe Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030

14.6.1. Injectable

14.6.2. Oral

14.7. Europe Mercury Poisoning Treatment Market Value Forecast, by Distribution Channel, 2018–2030

14.7.1. Hospital Pharmacies

14.7.2. Online Pharmacies

14.7.3. Retail Pharmacies

14.8. Europe Mercury Poisoning Treatment Market Value Forecast, by Country/Sub-region, 2018–2030

14.8.1. Germany

14.8.2. U.K.

14.8.3. France

14.8.4. Spain

14.8.5. Italy

14.8.6. Rest of Europe

14.9. Europe Mercury Poisoning Treatment Market Attractiveness Analysis

14.9.1. By Drug

14.9.2. By Type

14.9.3. By Treatment Type

14.9.4. By Form

14.9.5. By Route of Administration

14.9.6. By Distribution Channel

14.9.7. By Country/Sub-region

15. Asia Pacific Mercury Poisoning Treatment Market Analysis and Forecast

15.1. Introduction

15.2. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030

15.2.1. Chelating Agents

15.2.1.1. Dimercaprol or British anti-Lewisite (BAL)

15.2.1.2. Dimercaptosuccinic Acid (DMSA)

15.2.1.3. DMPS

15.2.1.4. Penicillamine

15.2.1.5. Others

15.2.2. Combination Therapy with Chelating Agents

15.2.3. Plasma Exchange Hemodialysis Plasmapheresis

15.3. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030

15.3.1. Acute Mercury Poisoning

15.3.2. Chronic Mercury Poisoning

15.4. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030

15.4.1. Supportive Treatment

15.4.2. Antidotal Treatment

15.5. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Form 2018–2030

15.5.1. Inorganic Mercury

15.5.2. Elemental Mercury

15.5.3. Organic Mercury

15.6. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030

15.6.1. Injectable

15.6.2. Oral

15.7. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Distribution Channel, 2018–2030

15.7.1. Hospital Pharmacies

15.7.2. Online Pharmacies

15.7.3. Retail Pharmacies

15.8. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Country/Sub-region, 2018–2030

15.8.1. Japan

15.8.2. China

15.8.3. India

15.8.4. Australia & New Zealand

15.8.5. Rest of Asia Pacific

15.9. Asia Pacific Mercury Poisoning Treatment Market Attractiveness Analysis

15.9.1. By Drug

15.9.2. By Type

15.9.3. By Treatment Type

15.9.4. By Form

15.9.5. By Route of Administration

15.9.6. By Distribution Channel

15.9.7. By Country/Sub-region

16. Latin America Mercury Poisoning Treatment Market Analysis and Forecast

16.1. Introduction

16.2. Latin America Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030

16.2.1. Chelating Agents

16.2.1.1. Dimercaprol or British anti-Lewisite (BAL)

16.2.1.2. Dimercaptosuccinic Acid (DMSA)

16.2.1.3. DMPS

16.2.1.4. Penicillamine

16.2.1.5. Others

16.2.2. Combination Therapy with Chelating Agents

16.2.3. Plasma Exchange Hemodialysis Plasmapheresis

16.3. Latin America Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030

16.3.1. Acute Mercury Poisoning

16.3.2. Chronic Mercury Poisoning

16.4. Latin America Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030

16.4.1. Supportive Treatment

16.4.2. Antidotal Treatment

16.5. Latin America Mercury Poisoning Treatment Market Value Forecast, by Form 2018–2030

16.5.1. Inorganic Mercury

16.5.2. Elemental Mercury

16.5.3. Organic Mercury

16.6. Latin America Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030

16.6.1. Injectable

16.6.2. Oral

16.7. Latin America Mercury Poisoning Treatment Market Value Forecast, by Distribution Channel, 2018–2030

16.7.1. Hospital Pharmacies

16.7.2. Online Pharmacies

16.7.3. Retail Pharmacies

16.8. Latin America Mercury Poisoning Treatment Market Value Forecast, by Country/Sub-region, 2018–2030

16.8.1. Brazil

16.8.2. Mexico

16.8.3. Rest of Latin America

16.9. Latin America Mercury Poisoning Treatment Market Attractiveness Analysis

16.9.1. By Drug

16.9.2. By Type

16.9.3. By Treatment Type

16.9.4. By Form

16.9.5. By Route of Administration

16.9.6. By Distribution Channel

16.9.7. By Country/Sub-region

17. Middle East & Africa Mercury Poisoning Treatment Market Analysis and Forecast

17.1. Introduction

17.2. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030

17.2.1. Chelating Agents

17.2.1.1. Dimercaprol or British anti-Lewisite (BAL)

17.2.1.2. Dimercaptosuccinic Acid (DMSA)

17.2.1.3. DMPS

17.2.1.4. Penicillamine

17.2.1.5. Others

17.2.2. Combination Therapy with Chelating Agents

17.2.3. Plasma Exchange Hemodialysis Plasmapheresis

17.3. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030

17.3.1. Acute Mercury Poisoning

17.3.2. Chronic Mercury Poisoning

17.4. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030

17.4.1. Supportive Treatment

17.4.2. Antidotal Treatment

17.5. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Form 2018–2030

17.5.1. Inorganic Mercury

17.5.2. Elemental Mercury

17.5.3. Organic Mercury

17.6. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030

17.6.1. Injectable

17.6.2. Oral

17.7. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Distribution Channel, 2018–2030

17.7.1. Hospital Pharmacies

17.7.2. Online Pharmacies

17.7.3. Retail Pharmacies

17.8. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Country/Sub-region, 2018–2030

17.8.1. GCC Countries

17.8.2. South Africa

17.8.3. Rest of Middle East & Africa

17.9. Middle East & Africa Mercury Poisoning Treatment Market Attractiveness Analysis

17.9.1. By Drug

17.9.2. By Type

17.9.3. By Treatment Type

17.9.4. By Form

17.9.5. By Route of Administration

17.9.6. By Distribution Channel

17.9.7. By Country/Sub-region

18. Competition Landscape

18.1. Market Player – Competition Matrix (By Tier and Size of companies)

18.2. Global Mercury Poisoning Treatment Market Position Analysis, by Company, 2019

18.3. Company Profiles

18.3.1. Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG

18.3.1.1. Company Description

18.3.1.2. Business Overview

18.3.1.3. Strategic Overview

18.3.1.4. SWOT Analysis

18.3.2. Genex Pharma

18.3.2.1. Company Description

18.3.2.2. Business Overview

18.3.2.3. Strategic Overview

18.3.2.4. SWOT Analysis

18.3.3. RECORDATI S.p.A. (Recordati Rare Diseases)

18.3.3.1. Company Description

18.3.3.2. Business Overview

18.3.3.3. Financial Overview

18.3.3.4. Strategic Overview

18.3.3.5. SWOT Analysis

18.3.4. Mylan N.V.

18.3.4.1. Company Description

18.3.4.2. Business Overview

18.3.4.3. Strategic Overview

18.3.4.4. Financial Overview

18.3.4.5. SWOT Analysis

18.3.5. Akorn, Incorporated

18.3.5.1. Company Description

18.3.5.2. Business Overview

18.3.5.3. Strategic Overview

18.3.5.4. Financial Overview

18.3.5.5. SWOT Analysis

18.3.6. EmeraMed Limited

18.3.6.1. Company Description

18.3.6.2. Business Overview

18.3.6.3. SWOT Analysis

18.3.7. Sanofi

18.3.7.1. Company Description

18.3.7.2. Business Overview

18.3.7.3. Strategic Overview

18.3.7.4. SWOT Analysis

List of Tables

Table 01 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030

Table 02 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030

Table 03 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 04 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type 2018–2030

Table 05 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030

Table 06 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 07 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 08 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 09 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 10 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030

Table 11 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030

Table 12 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 13 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030

Table 14 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030

Table 15 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 16 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 17 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 18 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030

Table 19 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030

Table 20 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 21 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030

Table 22 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030

Table 23 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 24 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 25 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 26 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030

Table 27 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030

Table 28 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 29 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030

Table 30 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030

Table 31 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 32 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 33 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 34 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030

Table 35 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030

Table 36 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 37 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030

Table 38 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030

Table 39 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 40 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 41 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 42 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030

Table 43 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030

Table 44 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 45 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030

Table 46 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030

Table 47 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 48 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030


• 英文レポート名:Mercury Poisoning Treatment Market (Drug: Chelating Agents [Dimercaprol or British anti-Lewisite {BAL}, Dimercaptosuccinic Acid {DMSA}, DMPS, Penicillamine, and Others], Combination Therapy with Chelating Agents, and Plasma Exchange Hemodialysis Plasmapheresis; Type: Acute Mercury Poisoning and Chronic Mercury Poisoning; Treatment Type: Supportive Treatment and Antidotal Treatment; Form: Inorganic Mercury, Elemental Mercury, and Organic Mercury; Route of Administration: Injectable and Oral; and Distribution Channel: Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030
• 日本語訳:水銀中毒治療の世界市場2020-2030:産業分析、規模、シェア、成長、動向、予測
• レポートコード:TMR2008055お問い合わせ(見積依頼・ご注文・質問)